SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on February 23, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a Regulation FD disclosure regarding the distribution of a corporate presentation to the investment community.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation (Exhibit 99.1) rather than a financial statement containing quantitative performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the availability of a "Corporate Presentation, Winter 2021" for use at industry conferences.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to utilize the attached presentation (Exhibit 99.1) from time to time.
- Forward-Looking Statements: The Company explicitly undertakes no obligation to update, supplement, or amend the materials in the presentation.
- Legal Status: The information is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the actual financial data and strategic outlook within Exhibit 99.1 (Corporate Presentation, Winter 2021), as this 8-K only references the document.
- Confirm that the presentation materials are not legally binding or guaranteed to be updated by the Company.
- Note the discrepancy in the request metadata: the filing is for BioSig Technologies, Inc., not Streamex Corp.